The LATAM Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Ledger.

Press releases published on March 16, 2026

Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Rhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial
From Foresight to Zeitgeist: Roger Spitz’s Prophetic 'Metaruptions' Define 2026 as the Era of Systemic Change
XS.com nombra a Simon-Peter Massabni como Jefe de Ventas Minoristas
XS.com Nomeia Simon-Peter Massabni como Head de Vendas de Varejo
International Military Exercise Cooperación 11 Projects Mato Grosso do Sul Across the Continent and Consolidates Zigurats, Dakila’s Headquarters, as a Strategic Base
Exousia Pro, Inc. Announces Favorable Litigation Settlement, Highlighting Significant Debt Elimination and Share Cancellation to Enhance Shareholder Value
Copa Holdings Announces Monthly Traffic Statistics for February 2026
Critical Metals Corp Appoints Chang Oh Turkmani to Its Advisory Board
Powered Land: Jet.AI and Consensus Core Complete Milestone Three of Canadian Hyperscale Data Center Projects
Milestone Pharmaceuticals to Present Data on CARDAMYST™ (etripamil) Nasal Spray at the 2026 American College of Cardiology Annual Scientific Session
Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation
Outlook Therapeutics Announces New $18.4 Million Non-Convertible Note Financing and Amendment to Existing Convertible Note
K2 Corporate Mobility’s growth leads the company to rebrand 
Pan American Energy Commences Drilling at the Tharsis Project
Maxus Mining Confirms Strong Polymetallic Results at the Quarry Antimony Property in British Columbia, Canada
Aprea Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
Cogent Biosciences Announces FDA Acceptance of New Drug Application for Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)
Lifecore Biomedical Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update
DPM Metals Announces Renewal of Normal Course Issuer Bid

Share this page:

Sign up for:

The LATAM Ledger

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.